Novartis India Limited – NSE:NOVARTIND.NS
Novartis India Limited stock price today
Novartis India Limited stock price monthly change
Novartis India Limited stock price quarterly change
Novartis India Limited stock price yearly change
Novartis India Limited key metrics
Market Cap | 17.47B |
Enterprise value | 17.32B |
P/E | 19.05 |
EV/Sales | 5.02 |
EV/EBITDA | 20.94 |
Price/Sales | 5.06 |
Price/Book | 2.28 |
PEG ratio | 0.47 |
EPS | 34.51 |
Revenue | 3.35B |
EBITDA | 1.16B |
Income | 851.9M |
Revenue Q/Q | 6.62% |
Revenue Y/Y | -11.53% |
Profit margin | 25.32% |
Oper. margin | 26.51% |
Gross margin | 39.73% |
EBIT margin | 26.51% |
EBITDA margin | 34.83% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNovartis India Limited stock price history
Novartis India Limited stock forecast
Novartis India Limited financial statements
| Jun 2023 | 906M | 202.6M | 22.36% |
|---|---|---|---|
| Sep 2023 | 787.6M | 236.8M | 30.07% |
| Dec 2023 | 845.4M | 265.7M | 31.43% |
| Mar 2024 | 811.7M | 146.8M | 18.09% |
| Payout ratio | 0% |
|---|
| 2016 | 1.46% |
|---|---|
| 2017 | 1.56% |
| 2019 | 1.47% |
| 2020 | 1.46% |
| 2022 | 1.7% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 8705700000 | 1.68B | 19.33% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 9249300000 | 1.80B | 19.47% |
| Jun 2023 | 31.2M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 13M | 0 | 0 |
| Dec 2023 | 5.2M | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Novartis India Limited alternative data
| Aug 2023 | 67 |
|---|---|
| Sep 2023 | 67 |
| Oct 2023 | 67 |
| Nov 2023 | 67 |
| Dec 2023 | 67 |
| Jan 2024 | 67 |
| Feb 2024 | 67 |
| Mar 2024 | 67 |
| Apr 2024 | 67 |
| May 2024 | 67 |
| Jun 2024 | 67 |
| Jul 2024 | 67 |
Novartis India Limited other data
| Insider | Compensation |
|---|---|
Mr. Sanjay Prabhakar Murdeshwar (1966) MD & Vice Chairman | $7,200,000 |
-
What's the price of Novartis India Limited stock today?
One share of Novartis India Limited stock can currently be purchased for approximately $780.5.
-
When is Novartis India Limited's next earnings date?
Unfortunately, Novartis India Limited's (NOVARTIND.NS) next earnings date is currently unknown.
-
Does Novartis India Limited pay dividends?
Yes, Novartis India Limited pays dividends and its trailing 12-month yield is 3.71% with 0% payout ratio. The last Novartis India Limited stock dividend of $10 was paid on 6 Sep 2025.
-
How much money does Novartis India Limited make?
Novartis India Limited has a market capitalization of 17.47B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.55% to 3.35B US dollars.
-
What is Novartis India Limited's stock symbol?
Novartis India Limited is traded on the NSE under the ticker symbol "NOVARTIND.NS".
-
What is Novartis India Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Novartis India Limited?
Shares of Novartis India Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Novartis India Limited's key executives?
Novartis India Limited's management team includes the following people:
- Mr. Sanjay Prabhakar Murdeshwar MD & Vice Chairman(age: 59, pay: $7,200,000)
-
How many employees does Novartis India Limited have?
As Jul 2024, Novartis India Limited employs 67 workers.
-
When Novartis India Limited went public?
Novartis India Limited is publicly traded company for more then 4 years since IPO on 7 Oct 2020.
-
What is Novartis India Limited's official website?
The official website for Novartis India Limited is novartis.in.
-
How can i contact Novartis India Limited?
Novartis India Limited can be reached via phone at +91 22 5024 3000.
Novartis India Limited company profile:
Novartis India Limited
novartis.inNSE
62
Drug Manufacturers - Specialty & Generic
Healthcare
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Mumbai, 400051
:
ISIN: INE234A01025
:
